Galectin Therapeutics SG&A Expense (Quarterly) Analysis

Galectin Therapeutics Inc (GALT)

3.56 +0.05 (+1.42%) USD | NASDAQ | May 01, 10:40

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2001. Upgrade now.

Date	Value
December 31, 2023	1.333M
September 30, 2023	1.434M
June 30, 2023	1.632M
March 31, 2023	1.543M
December 31, 2022	1.626M
September 30, 2022	1.524M
June 30, 2022	1.588M
March 31, 2022	1.877M
December 31, 2021	1.569M
September 30, 2021	1.631M
June 30, 2021	1.743M
March 31, 2021	1.418M
December 31, 2020	1.461M
September 30, 2020	1.146M
June 30, 2020	1.421M
March 31, 2020	1.44M
December 31, 2019	1.392M
September 30, 2019	1.36M
June 30, 2019	1.498M
March 31, 2019	1.721M
December 31, 2018	1.793M
September 30, 2018	1.175M
June 30, 2018	2.283M
March 31, 2018	1.88M
December 31, 2017	1.371M

Date	Value
September 30, 2017	0.911M
June 30, 2017	1.07M
March 31, 2017	1.174M
December 31, 2016	1.166M
September 30, 2016	1.248M
June 30, 2016	1.305M
March 31, 2016	2.437M
December 31, 2015	1.769M
September 30, 2015	1.435M
June 30, 2015	2.057M
March 31, 2015	1.704M
December 31, 2014	1.654M
September 30, 2014	1.498M
June 30, 2014	1.781M
March 31, 2014	2.072M
December 31, 2013	1.409M
September 30, 2013	2.353M
June 30, 2013	1.198M
March 31, 2013	1.456M
December 31, 2012	1.38M
September 30, 2012	1.487M
June 30, 2012	1.453M
March 31, 2012	1.052M
December 31, 2011	2.51M
September 30, 2011	1.378M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.146M

Minimum

Sep 2020

1.877M

Maximum

Mar 2022

1.507M

Average

1.498M

Median

Jun 2019

SG&A Expense (Quarterly) Benchmarks